Pfizer rises after Covid-19 vaccine sales outlook tops estimates
Wall Street's main indexes rose on Tuesday to record highs as a strong earnings season continued to lift sentiment for equities, while investors were looking ahead to the outcome of a critical Federal Reserve meeting.
The S&P 500 and Nasdaq notched record closing highs for a fourth straight session, while the Dow Jones Industrial Average posted its third straight record close and ended above 36,000 for the first time.
Pfizer shares rose 4.1% after the drugmaker said it expected 2021 sales of the Covid-19 vaccine it developed with German partner BioNTech to reach $36 billion.
Overall, third-quarter earnings have come in better-than-expected for U.S. companies as the economy continues to bounce back from the coronavirus pandemic. With some 320 companies having reported so far, S&P 500 earnings are expected to have climbed 40.2% in the third quarter from a year ago, according to Refinitiv IBES.
"From a fundamental perspective, there is a strong underpinning for the performance of the broad equity market complex," said Bill Northey, senior investment director at US.
Bank Wealth Management.
"The next several days and weeks will include significant developments on the policy front, and we are watching that very closely because as we transition out of the earnings reporting season many of the macro factors will start to take center stage again.”
The Dow Jones Industrial Average rose 138.79 points, or 0.39%, to 36,052.63, the S&P 500 gained 16.98 points, or 0.37%, to 4,630.65 and the Nasdaq Composite added 53.69 points, or 0.34%, to 15,649.60.
The economically sensitive Dow Jones Transportation Average soared 6.9% to hit an all-time high, lifted by a 108% surge in shares of Avis Budget after the car-rental firm reported earnings.
Nine of 11 S&P 500 sectors ended positive with materials leading the way, up 1.1%. The energy sector fell 1%.
No comments:
Post a Comment